Skip to main content
Clinical Trials/NCT02666235
NCT02666235CompletedPhase 2

A Randomised Controlled Trial of the Effect of Remote Ischaemic Conditioning on Coronary Endothelial Function in Patients with Angina.

NHS National Waiting Times Centre Board2 sites in 1 country60 target enrollmentStarted: July 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
60
Locations
2
Primary Endpoint
Coronary artery diameter change

Study Overview

Brief Summary

Intermittent arm cuff inflation reduces the extent of heart muscle injury at the time of cardiovascular injury. The intervention is known as remote ischaemic conditioning (RIC) however the mechanisms by which RIC acts are incompletely understood.

One mechanism that might explain the benefits of RIC is an improvement in coronary artery function which in turn might help improve blood flow to heart muscle.

The investigators will perform a randomised controlled study of RIC in a minimum of 60 patients with known or suspected angina and in whom coronary angiography with angioplasty would be considered.

Following informed consent before the invasive procedure, the patient will be randomly assigned to the intervention group (cuff inflation protocol) or the control group (cuff placement, no inflation; sham protocol). Following initial coronary angiography, endothelial function will be assessed by intra-coronary infusion of acetylcholine in incremental doses. Coronary diameter will be measured after the procedure using quantitative coronary angiography, by a trained observer blinded to the allocated group. Since a neuro-hormonal response may potentially mediate RIC, a blood test will be performed before and after cuff placement in all patients (active and control groups) to measure circulating molecules known to regulate blood vessel function which may be implicated in a RIC-mediated effect on coronary artery tone.

This study may provide clinically relevant insights into the mechanisms of action of RIC in patients with coronary heart disease.

Detailed Description

Intermittent arm cuff inflation reduces the extent of heart muscle injury at the time of cardiovascular injury. The intervention is known as remote ischaemic conditioning (RIC) however the mechanisms by which RIC acts are incompletely understood. One mechanism that might explain the benefits of RIC is an improvement in coronary artery function which in turn might help improve blood flow to heart muscle.

The primary aim is to determine whether intermittent inflation of a blood pressure cuff for 5 min periods at 200 mmHg on 4 occasions separated by 5 minute intervals can improve coronary vascular function compared to cuff placement with no cuff inflation. A secondary aim is to determine whether or not RIC alters the circulating concentrations of small molecules and hormones in systemic blood that regulate coronary endothelial function.

The investigators will perform a randomised controlled trial of RIC in a minimum of 60 patients with known or suspected angina and in whom coronary angiography with angioplasty would be considered. A screening log will be prospectively recorded. In order to be enrolled prior knowledge of the coronary anatomy and disease is necessary, and this information can be obtained by screening referrals for invasive angiography following non-invasive CT coronary angiography, or staged invasive management when angioplasty is intended following initial invasive angiography.

The protocol had initially involved two coronary angiograms with coronary reactivity testing on the same day, with the first angiogram taking place before the RIC-COR intervention and the second angiogram taking place immediately afterwards. However, after enrolling 10 participants it was evident that the total procedure time and hospital stay was unduly long and impractical. Therefore, following consultation with the trial biostatistician, funder and ethics committee, the protocol was amended and the initial angiogram was removed (May 2012). There were no other changes to the study design. Following a change in service arrangements for elective referrals for coronary angioplasty in our hospital, and constraints around staff illness and availability, recruitment was temporarily suspended on logistical grounds (September 2013 to November 2014).

Following informed consent before the invasive procedure, the patient will be randomly assigned to the intervention group (cuff inflation protocol) or the control group (cuff placement, no inflation; sham protocol). The clinical team will be blind to treatment group assignment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Triple (Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 or over
  • Known or suspected coronary artery disease
  • A clinical indication for coronary angiography.

Exclusion Criteria

  • Myocardial infarction within 2 weeks
  • History of coronary artery bypass surgery
  • Second or third degree atrioventricular block
  • Written informed consent.

Outcomes

Primary Outcomes

Coronary artery diameter change

Time Frame: Intra-procedure

The net percentage change in mean coronary artery diameter (endothelial function) following intra-coronary administration of study drug (ACh or glyceryl trinitrate) compared to baseline.

Secondary Outcomes

  • Mean percentage coronary vasoconstriction(Intra-procedure - After intracoronary infusion of intra-coronary acetylcholine)
  • Epicardial coronary artery spasm(Intra-procedure - During intra-coronary infusion of acetylcholine)
  • Microvascular spasm(Intra-procedure - During intra-coronary infusion of acetylcholine)
  • Coronary endothelial dysfunction(Intra-procedure - After intracoronary infusion of intra-coronary acetylcholine)
  • ST-segment deviation(Intra-procedure - During intra-coronary infusion of acetylcholine)
  • Mean percentage change in coronary lumen diameter (delta CAD)(Intra-procedure - After intracoronary injection of glyceryl trinitrate)
  • Mean percentage coronary vasodilatation(Intra-procedure - After intracoronary injection of glyceryl trinitrate)
  • Circulating molecules reflecting endothelial function and oxidative stress(Peri-procedure; from baseline up to 2 hours)

Investigators

Sponsor
NHS National Waiting Times Centre Board
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Colin Berry

Professor of Cardiology and Imaging

NHS National Waiting Times Centre Board

Study Sites (2)

Loading locations...

Similar Trials